Effects of renal impairment on the pharmacokinetics, safety, and tolerability of pudexacianinium (ASP5354) after IV administration: a mechanistic exploration - Tomoki Kojima; Masako Saito; Toshihiro Matsuda; Neal Simmons; Masanori Nagata; Mayuko Miyagawa; Tomasz Wojtkowski; Sayuri Guro; Akira Koibuchi; Kimberly S. Cruz; Joel M. Neutel; Almena L. Free; et al. (European Journal of Clinical Pharmacology, 2026)